Share on StockTwits

HeartWare International (NASDAQ:HTWR) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a note issued to investors on Friday. The firm currently has a $105.70 price target on the stock. Zacks‘s target price suggests a potential upside of 28.34% from the company’s current price.

Shares of HeartWare International (NASDAQ:HTWR) opened at 82.36 on Friday. HeartWare International has a 1-year low of $69.31 and a 1-year high of $105.84. The stock’s 50-day moving average is $87.99 and its 200-day moving average is $92.05. The company’s market cap is $1.399 billion.

HeartWare International (NASDAQ:HTWR) last announced its earnings results on Thursday, July 31st. The company reported ($0.29) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.74) by $0.45. The company had revenue of $70.10 million for the quarter, compared to the consensus estimate of $67.01 million. On average, analysts predict that HeartWare International will post $-2.90 earnings per share for the current fiscal year.

Heartware International, Inc (NASDAQ:HTWR) develops and manufactures small implantable heart pumps, or ventricular assist devices, for the treatment of advanced heart failure.

To view Zacks’ full report, visit Zacks’ official website.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.